Hospital Universitario 12 de Octubre
One of Madrid's largest hospitals, a leading site for lung cancer and myeloma trials and for academic CAR-T development.
The Hospital Universitario 12 de Octubre and its research institute i+12 host the H12O-CNIO Lung Cancer Clinical Research Unit led by Luis Paz-Ares, one of the most active investigators in small-cell and non-small-cell lung cancer trials including the tarlatamab programme, and a haematology department under Joaquín Martínez-López that pioneered next-generation sequencing for minimal residual disease in myeloma and co-developed the academic BCMA CAR-T ARI-0002h with Hospital Clínic. The hospital is a major transplant centre, runs paediatric oncology and neuro-oncology services and a phase 1 unit. Its proximity to the CNIO underpins joint translational programmes.
- H12O-CNIO Lung Cancer Unit
- Myeloma and MRD by NGS
- Academic CAR-T
- Transplantation
- Phase 1 unit
Pages like this
not linked directly; found by shared links- TrialDeLLphi-305
Shares DLL3, Tarlatamab, Durvalumab, Small-cell lung cancer.
- InstitutionCancer Center Clínica Universidad de Navarra / CIMA
Shares Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing, Multiple myeloma, CAR-T cell therapy.
- IdeaDetect tumours changing cell type from RNA in the blood
Shares DLL3, Tarlatamab, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialDeLLphi-304
Shares DLL3, Tarlatamab, Small-cell lung cancer.
- PairingSequencing DLL3 engager and B7-H3 ADC in relapsed SCLC
Shares DLL3, Tarlatamab, Small-cell lung cancer.
- IdeaPlan the second CAR-T target before the first one is lost
Shares BCMA, Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing, Multiple myeloma.
- IdeaSubtype-directed therapy for SCLC (ASCL1 / NEUROD1 / POU2F3 / inflamed)
Shares DLL3, Tarlatamab, Small-cell lung cancer.
- InstitutionSylvester Comprehensive Cancer Center, University of Miami
Shares Minimal / molecular residual disease (MRD), MRD / molecular residual disease testing, Multiple myeloma, Acute myeloid leukaemia.